| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |